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SUMMARY.-Circulating antibody response to flagella antigen has been
measured in three groups of Sprague-Dawley rats after feeding with 7.12.DMBA
in an attempt to differentiate carcinogen and tumour growth as causative
agents in the depression of immune response seen in these animals. DMBA fed
female rats developing tumours had progressive depression ofboth primary and
secondary response as compared to control animals, and 7S and 19S antibody
fractions were equally affected. Removal of tumours did not result in recovery
of response. Attempts to prevent tumour development by mammectomy after
DMBA feeding were unsuccessful, but the similar number of tumours found in
this group was associated with an equal degree of antibody depression to that
seen in the first experiment. Male animals fed DMBA did not develop malig-
nant tumours, and showed no depression of immune response. Results suggest
that tumour development plays a part in the depression of circulating antibody
response seen in these animals, but that it is not directly related to the number
of tumours, and is not reversible by tumour excision.
THE immune status of a tumour-bearing host is a complex system, and an
understanding of the relationship between tumour growth and immune response
is of great importance, both in regard to the pathogenesis of cancer, and to the
possibility of treating it by immunotherapy.
Studies of clinical cancer suffer from the limitation that all experimental work
must be done after a tumour has arisen. Here it is now well demonstrated that a
depression of immune response is present, particularly in relation to cellular
immunity (Hughes and Mackay, 1965; Brunschwig et al., 1965) and also in regard
to circulating antibody production. However, in the latter case, depression
occurs only at a late stage of the disease (Lytton et al., 1964).
This immune depression has given rise to two major points of view, the first
that tumours arise because the immune mechanism of the host is depressed, and
the second that this depression is due to an effect of the tumour on the host. If
the antigenicity of tumours is accepted, it would seem on basic grounds that at
least some degree of immune depression, temporary or permanent, must exist at
the time of tumour induction, otherwise the host would react against the foreign
antigens and destroy the tumour a concept strongly propounded by Burnet
(1964). Yet recently Southam (1968), reviewing the immune status of patients
with cancer, states that there is no present evidence that abnormal immune
responsiveness precedesthe development of cancer, although this possibility cannot
be excluded. This would suggest that the tumour itself might be causing immune
depression, and Hughes and Mackay (1965) found some evidence of improved
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immune competence after successful excision of a cancer. This has recently
received confirmation (Israel et al., 1968).
Although these two viewpoints are frequently put forward as being mutually
exclusive, this is not necessarily so, for a cancer arising at a time of diminished
immune competence could well later exert an additive effect, although a mecha-
nism for such an effect has not yet been defined. However, the presence and
relative importance of the two factors is more than an academic question, having
profound significance inregard to cancer immunotherapy. Ifthe state ofimmuno-
logical unreactivity which appears to exist between host and tumour has preceded
the development of the tumour, the primary defect would be in the host, and the
chances ofstimulating an immune response would seem to be correspondingly poor.
If, however, the immune paralysis is the result ofthe tumour, and possiblyrelated
directly to its extent, removal of part or all, by surgical or other means, might be
expected to lead to some recovery of the immune response, with the likelihood of
enhancement by procedures designed to stimulate immunity.
Many approaches to this problem have been made in the experimental animal.
Artificial depression of the immune response has led to enhanced carcinogenicity
by viruses (Allison and Law, 1968) and to a lesser extent with chemicals (Miller
et al., 1963). Studies of the effect of carcinogens on immune response has shown
that both carcinogenic viruses (Ceglowski and Friedman, 1968) and chemicals
(Stjernsward, 1965, 1966) have a depressant effect on circulating antibody response
which occurs early and is longlasting. However, studies of cellular immunity (as
detected by allograft rejection) has shown that depression is evident only at the
time tumours appear (Stjernsward, 1965). These studies have concentrated on
the period before tumours are detected, and it is still not possible to state with
certainty whether the immune depression present during experimental carcino-
genesis is entirely due to the carcinogenic agent, or whether the developing tumours
contribute in small or large part. (Extrapolation of tumour growth rate curves
makes it obvious that tumour induction must frequently occur after a very short
latent period and a considerable time before the tumours become palpable.)
Further information is required on this point, in relation to both circulating anti-
body response and cellular immune response.
This paper reports work attempting to elucidate the part played by the
tumours themselves in the aetiology of depressed circulating antibody response.
The 7S and 19S antibody response to flagella has been followed during the
development of DMBA induced mammary carcinoma in the Sprague-Dawley
rat. This system was chosen for several reasons. Mammary tumour induction
is reliable and the latent period is short, while tumours of other organs are un-
common. The mammary tumours do not metastasize, so that the total mammary
tumour present is subcutaneous and readily observed. Furthermore, it would
seem at present that chemically induced tumours are more closely related to
common human solid tumours than are virus or transplanted neoplasms. Flagella
is an ideal antigen in that it leads to a strong, reproducible and prolonged
antibody response.
EXPERIMENTAL DESIGN
Three groups of experiments were carried out.
Experiment 1
In the first, the 7S and 19S antibody response, both primary and secondary,
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in carcinogen-fed female rats was compared with a control group of female rats
who were not fed carcinogen. When tumour growth was established, and before
testing the secondary immune response, the carcinogen-fed group was divided
into 2 sub-groups, one of which had all palpable tumours surgically removed.
Nine experimental and 8 control female rats were injected with flagella 8
weeks afterthe experimental group received the first dose ofcarcinogen. Fourteen
weeks later, all tumours were removed from 4 of the experimental group and
tumours were left undisturbed in the other 5. At 19 weeks, a second dose of
flagella was given to induce a secondary response.
Experiment 2
To further analyse the relative importance of carcinogen and tumour, an
experimental system was devised to prevent tumour development by performing
mammectomy shortly after feeding with carcinogen. Antibody response to
flagella was measured in 8 female rats who had undergone bilateral apparently
total mammectomy. Four randomly chosen litter-mates who were not fed
carcinogen were used as a further group of normal controls.
Experiment 3
When it became apparent that the object ofExperiment 2 had not been wholly
realized, an attempt was made to overcome this problem by using male rats, as
tumour induction by intra-gastric DMBA is rare in males, and such mammary
tumours as do occur are usually benign fibroadenomas.
Thirteen male rats were randomly divided into a group of 8 animals who were
fed carcinogen and 5 who acted as controls. The antibody response to flagella
was compared in the 2 groups.
MATERIALS AND METHODS
Experimental animals and tumour induction
Random-bred Sprague-Dawley rats from our own colony were used for these
experiments. All groups and sub-groups were determined by random division of
litters born on the same day. Mammary tumours were induced by the intra-
gastric installation of 4 doses each of 10 mg. 7.12.DMBA in 1 ml. of sesame oil at
weekly intervals commencing at age 50 ± 1 days. Rats were palpated weekly
commencing 6 weeks after the first feeding. Where indicated by the experimental
protocol, tumours were excised by surgical dissection under nembutal anaesthesia.
Tumours were examined histologically at excision or post-mortem.
Antigen
Flagella were removed from motile Salmonella adelaide (strain SW1338, H
antigen fg; 0 antigen 35) according to the method of Ada et al. (1964).
Rats were injected intraperitoneally with 10 jtg. offlagella suspended in 0-25 ml.
ofsaline, 8 weeks after the first dose ofcarcinogen. In group 1, a second injection
of 10#,g. flagella was given intraperitoneally, 19 weeks after the first antigen
injection, to induce a secondary response.
Animals were bled at regular intervals. Serum collected from 0*5 ml. of blood
taken from the tail vein was stored at -20° C.
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Antibody assay
Anti-flagella antibody titres were determined by immobilization ofSalmonella
derby (strain SW721, H antigen fg; 0 antigen 1, 4, 12 which shares the H but not
the 0 antigen with S. adelaide). The method was slightly modified from that
described by Nossal (1959) and Ada et al. (1964). Serial two-fold dilutions of the
immune sera were made in saline contained in " microtiter " trays.
One volume (0.025 ml.) of a suspension of motile S. derby in dilute bacterial
broth (106 organisms per ml.) was added and the suspensions incubated at room
temperature for 30 minutes. Samples of each dilution were transferred to a
microscope slide and examined for bacterial immobilization. The end point
taken was that dilution which produced 80% immobilization.
Mercaptoethanol reduction
Serum samples were diluted in phosphate buffered saline pH 7-2 containing
2-mercaptoethanol (ME) so that the final mixtures contain 10% serum and
0.1 M ME. After incubation at 37° C. for 1 hour, the mixtures were diluted and
tested for bacterial immobilization.
Maammectomy
Bilateral excision of mammary tissue was carried out in one group of animals
commencing 1 week after the last dose of DMBA, using a method modified from
that of Dux (1962). Each side was dissected separately, 1 week apart, with
removal of a length ol skin 1 cm. wide to include all nipples, in continuity with all
detectable subcutaneous mammary tissue from midline to flank.
RESULTS
Experiment 1
The total antibody response in the first experimental and control groups of
female rats is shown in Fig. 1, where individual and mean titres for the two groups
are shown. In individual animals, there was no relationship between antibody
response and number of tumours present. The group fed carcinogen had a con-
sistently depressed response of moderate degree as compared to the normal
TABLE I.-Mercaptoethanol Sensitivity ofSerafrom DMBA Treated and
Untreated Female Rats Injected with Flagellafrom Salmonella adelaide
Sera from untreated rats Sera from DMBA treated
(mean titre Log. 2) rats (mean titre Log. 2)
Time
(weeks) Number rats Control After M.E. Number rats Control After M.E.
1* 8 9 9 6-0 8 8-5 4-1
2 8 11 0 9 7 8 8-6 7-1
3 8 11.1 9 9 . 8 9.5 8-7
8 8 10.9 10.1 . 8 8-1 7-2
12 8 11-4 10 1 . 8 7-7 5.5
19t . 8 11.0 11.0 . 8 6-1 6-0
20 5 17-4 16-2 8 14-5 13-4
22 . ,=) 16-6 15 8 8 14-4 14-4
* After first injection 10 jig. flagella.
t Second injection 10 ,ig. flagella.
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controls. This was statistically significant; e.g. at 8 weeks " t " = 2.28, 0.05 >
P > 0*02; at 16 weeks " t " = 4*38, P =< 001. After tumour excision, there
was no difference betweenthe two sub-groups in eitherprimary or secondary anti-
body response (at 16th week " t " = 009, P => 0-5).
The results of ME reduction of the sera taken from these animals are set out
in Table I. The ratio of 19S and 7S antibodies, while varying at different stages
ofthe immune process, did not differ significantly between the carcinogen fed and
control groups, showing that both types of antibody were equally reduced in the
carcinogen treated group.
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FIG. 1.-Primary and secondary antibody responses in normal and DMBA-fed female rats.
Arrows indicate the time rats were injected intraperitoneally with 10 ,ug. Salmonella adelaide
flagella. Each point on the curves represents the mean antibody titre. Extreme values
are shown by vertical lines. Total numbers of tumours present in the DMBA-fed rats are
shown by the solid vertical bars. The " control " curve represents a subgroup of the
normal animals who were not given a second injection offlagella.
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Each animal in the carcinogen fed group developed an average of 3 tumours
during the period of the experiment. The tumours were adenocarcinomas of
varying degrees of malignancy, the histology being similar to that described by
Young, Cowan and Sutherland (1963) after high doses of DMBA. No tumours
underwent metastasis.
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FIG. 2. Primary antibody response in DMBA-treated female mammectomized rats and normal
untreated rats injected with 10 ,ug. flagella. Other details as for Fig. 1.
Experiment 2
Fig. 2 shows the antibody responses in a group of female rats mammectomized
after feeding with carcinogen, and a control group of normal animals. Mammec-
tomy was technically unsuccessful in that it failed to prevent the development of
mammary tumours. Although the tumours appeared slightly later, the average
number oftumours was the same as that found in Experiment 1. A depression of
primary antibody response similar to that seen in EJxperiment 1 was obtained.
Experiment 3
The individual and mean antibody responses in experimental and control
groups of male rats are set out in Fig. 3. Unlike the two groups of female rats,
the carcinogen fed male rats showed a slightly better antibody response than the
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control animals. The progressive depression ofimmune response seeninthe female
carcinogen fed group was not evident in the corresponrding male group.
Tumours developed in 3 male rats fed with carcinogen, each of the 3 animals
having one fibroadenoma of benign histological appearance.
DISCUSSION
Investigations of immune depression during chemical carcinogenesis have so
far concentrated on the role of the carcinogen. The possibility of the tumour
being a causative factor has received little attention. Yet, in clinical cancer,
there is much evidence that the tumour itself may be important. Immune
depression becomes progressively more marked as the disease becomes more
extensive (Lytton et al., 1964; Krant et al., 1968), and surgical excision sometimes
leads to recovery (Israel et al., 1968).
The results of Experiment 1 show a diminishing circulating antibody response,
both primary and secondary, in the carcinogen fed rats, and this response could be
due either to the carcinogen or to the developing tumours. This prolonged and
progressive depression would suggest a tumour effect, as one would expect the
carcinogen to have its maximum effect immediately, followed by progressive
recovery. This was in fact the result obtained by Stjernsward (1965), who
measured antibody response immediately after carcinogen administration. We
commenced our experiment later, at a time when Stjernsward was noting antibody
recovery, in order to minimize the efFect of carcinogen in favour of a possible effect
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of tumour development. However, tumour excision during the course of the
experiment did not give recovery of either primary or secondary response so that
any effect that the tumour might have on circulating antibody response does not
seem to be reversible by removal of the tumour mass.
Experiment 2 did not help elucidate this problem because attempted mam-
mectomy did not prevent tumour growth, but the presence of a similar degree of
depression to that seen in Experiment 1 confirms the results obtained in the first
experiment. (From this experiment, where very wide removal of nipple line and
subcutaneous tissue was effected, it would seem that total excision of mammary
tissue in the adult rat is extremely difficult to achieve. Other workers have had
the same result (Fekete, 1939). It is of considerable interest that removal ofsuch
a wide area of mammary tissue should not alter the total number of tumours
developing. Mammectomy could perhaps be carried out more effectively in the
weanling rat, before feeding with DMBA, but this would alterthe body distribution
of DMBA to such an extent that the animals could not be considered to be satis-
factory controls.)
In Experiment 3, the lack of depression of antibody response seen in the
carcinogen-fedgroup without any malignant tumours also suggests thatthetumour
itself may be the cause of depression seen in the female carcinogen-fed group. It
again supports the belief that any immuno-suppressive effect of the carcinogen
has worn offby the time ofthe depression seen in the female tumour bearing rats.
No explanation is obvious for the better response of the male carcinogen fed
controls when compared with the normal male animals. Little work has been
reported on the detailed metabolism of DMBA in male rats. Although other
workers investigating this problem have not specifically mentioned sex differences,
they do appear to have obtained immuno-suppression in male mice treated with
carcinogen (Stjernsward, 1965). However, these experiments were short-term
and carried out immediately after carcinogen administration.
Thus, the results of this work would suggest that tumour growth does play a
part in the depression of circulating antibody response seen in animals bearing
tumours induced with chemical carcinogens. This depression is not directly
related to the number or total mass oftumour present, and once established is not
reversible by tumour excision. However, further experimental models are
required to differentiate completely the effects ofthe inducing agent from those of
the tumour itself.
Results of investigations in clinical cancer suggest that similar studies in
relation to delayed hypersensitivity response will be even more important in
assessing the effect of tumour growth on the immune status of the host.
We wish to thank Dr. W. J. Halliday for his interest and advice in the conduct
of this work.
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